Department of Maternal and Child Health, Obstetrics and Gynecology Clinic, University Hospital of Udine
Udine, 33100, Italy
Location status: Recruiting
NCT Number: NCT06831747
The study hypothesis is that surgical treatment performed with MiniLap results in reduced postoperative pain in a population of patients undergoing prophylactic laparoscopic adnexal surgery. The primary objectives are to assess differences in operative duration, intraoperative blood loss, and postoperative complications in patients undergoing bilateral laparoscopic adnexectomy performed with standard laparoscopy versus MiniLap. The secondary objectives of this study are to compare postoperative pain and patient satisfaction with aesthetic outcomes.
Patients with BRCA 1/2 mutations undergoing prophylactic surgery will be assigned to either MiniLap or standard laparoscopic treatment based on randomization. Subsequently, the necessary study data will be collected using the hospital's electronic management system and medical records.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Udine, 33100, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In standard laparoscopy (S-LPS), the initial laparoscopic access was performed at the umbilical level using open laparoscopy (Hasson technique). The subsequent accesses were carried out in the right and left iliac fossa. In the S-LPS, these accesses are performed using a 5mm trocars. Finally, a 5mm ancillary trocar was placed in the suprapubic region to use instruments such as bipolar forceps, irrigators, and scissors. The subsequent surgical steps were identical for both techniques.
In the MiniLap® Percutaneous Surgical System (PSS), the initial laparoscopic access was performed at the umbilical level using open laparoscopy (Hasson technique). The subsequent two accesses were carried out in the right and left iliac fossa. These latter accesses are directly performed using MiniLap® with a 2.4mm incision. Finally, a 5mm ancillary trocar was placed in the suprapubic region to use instruments such as bipolar forceps, irrigators, and scissors. The subsequent surgical steps were identical for both techniques.
Time frame: From enrollment to 30 days postoperatively
The primary objectives are to assess differences in:
operative time (minutes), intraoperative blood loss (mL), postoperative complications (clavien dindo classification) in patients undergoing bilateral laparoscopic adnexectomy performed with standard laparoscopy versus MiniLap.
Time frame: From enrollment to 2 days postoperatively.
The secondary objective of this study is to compare postoperative pain (VAS 0-10; higher scores mean worse)
Time frame: From enrollment to 60 days postoperatively.
The secondary objective of this study is to compare patient satisfaction with aesthetic outcomes using a VAS scale (0-10, with higher scores indicating greater satisfaction).
Contact information is provided by the study sponsor or research team.
Azienda Sanitaria-Universitaria Integrata di Udine
Other
MiniLap Vs Standard Laparoscopy in Prophylactic Bilateral Salpingo-Oophorectomy in BRCA-Mutated Patients: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06177171
ATM Gene Mutation, BRCA Mutation
San Francisco, California, United States
View Trial DetailsNCT05769517
Adnexal Diseases, BRCA Mutation
Rome, Italy
View Trial DetailsNCT06395519
Adnexal Diseases, Advanced or Metastatic Solid Tumors
Phoenix, Arizona, United States
View Trial DetailsNCT05097274
ATM Gene Mutation, BRCA Mutation
London, Sutton, Surrey, United Kingdom
View Trial Details